前のページに戻る
この文献は全文を取り寄せることができます
JDreamⅢ複写サービスから文献全文の複写（冊子体のコピー）をお申込みできます。
ご利用には、G-Searchデータベースサービスまたは、JDreamⅢのIDが必要です。
ご利用には、G-Searchデータベースサービスまたは、JDreamⅢのIDが必要です。
既に、G-Searchデータベースサービスまたは、JDreamⅢのIDをお持ちの方
JDreamⅢ複写サービスのご利用が初めての方
取り寄せる文献のタイトルと詳細
文献
J-GLOBAL ID：202202211476321820
整理番号：22A0669345
MiR-182-5pはUBE2Tを抑制して腎明細胞癌の腫瘍形成を抑制
MiR-182-5p inhibits the tumorigenesis of clear cell renal cell carcinoma by repressing UBE2T
Wu Yucai
(Department of Urology, Peking University First Hospital, Beijing, People’s Republic of China)
,
Wu Yucai
(Institute of Urology, Peking University, Beijing, People’s Republic of China)
,
Wu Yucai
(National Urological Cancer Center, Beijing, People’s Republic of China)
,
Wu Yucai
(Urogenital Diseases (Male) Molecular Diagnosis and Treatment Center, Peking University, Beijing, People’s Republic of China)
,
Zhang Cuijian
(Department of Urology, Peking University First Hospital, Beijing, People’s Republic of China)
,
Zhang Cuijian
(Institute of Urology, Peking University, Beijing, People’s Republic of China)
,
Zhang Cuijian
(National Urological Cancer Center, Beijing, People’s Republic of China)
,
Zhang Cuijian
(Urogenital Diseases (Male) Molecular Diagnosis and Treatment Center, Peking University, Beijing, People’s Republic of China)
,
Peng Ding
(Department of Urology, The First Affiliated Hospital of Zhejiang University School of Medicine, Zhejiang, People’s Republic of China)
,
He Shiming
(Department of Urology, Peking University First Hospital, Beijing, People’s Republic of China)
,
He Shiming
(Institute of Urology, Peking University, Beijing, People’s Republic of China)
,
He Shiming
(National Urological Cancer Center, Beijing, People’s Republic of China)
,
He Shiming
(Urogenital Diseases (Male) Molecular Diagnosis and Treatment Center, Peking University, Beijing, People’s Republic of China)
,
Huang Cong
(Department of Urology, Peking University First Hospital, Beijing, People’s Republic of China)
,
Huang Cong
(Institute of Urology, Peking University, Beijing, People’s Republic of China)
,
Huang Cong
(National Urological Cancer Center, Beijing, People’s Republic of China)
,
Huang Cong
(Urogenital Diseases (Male) Molecular Diagnosis and Treatment Center, Peking University, Beijing, People’s Republic of China)
,
Qian Jinqin
(Department of Urology, Peking University First Hospital, Beijing, People’s Republic of China)
,
Qian Jinqin
(Institute of Urology, Peking University, Beijing, People’s Republic of China)
,
Qian Jinqin
(National Urological Cancer Center, Beijing, People’s Republic of China)
,
Qian Jinqin
(Urogenital Diseases (Male) Molecular Diagnosis and Treatment Center, Peking University, Beijing, People’s Republic of China)
,
Zhu Weijie
(Department of Urology, Peking University First Hospital, Beijing, People’s Republic of China)
,
Zhu Weijie
(Institute of Urology, Peking University, Beijing, People’s Republic of China)
,
Zhu Weijie
(National Urological Cancer Center, Beijing, People’s Republic of China)
,
Zhu Weijie
(Urogenital Diseases (Male) Molecular Diagnosis and Treatment Center, Peking University, Beijing, People’s Republic of China)
,
Feng Ninghan
(Wuxi No 2 People’s Hospital, Jiangsu, People’s Republic of China)
,
Gong Yanqing
(Department of Urology, Peking University First Hospital, Beijing, People’s Republic of China)
,
Gong Yanqing
(Institute of Urology, Peking University, Beijing, People’s Republic of China)
,
Gong Yanqing
(National Urological Cancer Center, Beijing, People’s Republic of China)
,
Gong Yanqing
(Urogenital Diseases (Male) Molecular Diagnosis and Treatment Center, Peking University, Beijing, People’s Republic of China)
,
Li Xuesong
(Department of Urology, Peking University First Hospital, Beijing, People’s Republic of China)
,
Li Xuesong
(Institute of Urology, Peking University, Beijing, People’s Republic of China)
,
Li Xuesong
(National Urological Cancer Center, Beijing, People’s Republic of China)
,
Li Xuesong
(Urogenital Diseases (Male) Molecular Diagnosis and Treatment Center, Peking University, Beijing, People’s Republic of China)
,
Zhou Liqun
(Department of Urology, Peking University First Hospital, Beijing, People’s Republic of China)
,
Zhou Liqun
(Institute of Urology, Peking University, Beijing, People’s Republic of China)
,
Zhou Liqun
(National Urological Cancer Center, Beijing, People’s Republic of China)
,
Zhou Liqun
(Urogenital Diseases (Male) Molecular Diagnosis and Treatment Center, Peking University, Beijing, People’s Republic of China)
資料名：
Human Cell (Web)
(Human Cell (Web))
巻： 35 号： 2 ページ： 542-556 発行年： 2022年
JST資料番号： U0492A ISSN： 1749-0774 資料種別： 逐次刊行物 (A)
記事区分： 原著論文 発行国： ドイツ (DEU) 言語： 英語 (EN)
JDreamⅢ複写サービスとは
JDreamⅢ複写サービスは、学術文献の全文を複写（コピー）して取り寄せできる有料サービスです。インターネットに公開されていない文献や、図書館に収録されていない文献の全文を、オンラインで取り寄せることができます。J-GLOBALの整理番号にも対応しているので、申し込みも簡単にできます。全文の複写（コピー）は郵送またはFAXでお送りします
※ご利用には、G-Searchデータベースサービスまたは、JDreamⅢのIDが必要です
※初めてご利用される方は、JDreamⅢ複写サービスのご案内をご覧ください。
※ご利用には、G-Searchデータベースサービスまたは、JDreamⅢのIDが必要です
※初めてご利用される方は、JDreamⅢ複写サービスのご案内をご覧ください。